Stocktoria
HEALTHEQUITY, INC. HQY
HEALTHEQUITY, INC. financials (annual)
Bars are annual figures from 2017 to 2026; red bars are negative (a loss or cash outflow).
| Metric | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $1.3B | $1.2B | $999.6M | $861.7M | $756.6M | $733.6M | $532.0M | $287.2M | $229.5M | $178.4M |
| Gross profit | $913.1M | $777.3M | $622.6M | $491.9M | $424.8M | $415.3M | $325.9M | $181.2M | $134.9M | $106.4M |
| R&D expense | $262.5M | $239.5M | $218.8M | $193.4M | $157.4M | $124.8M | $77.6M | $35.1M | $27.4M | $22.4M |
| Operating income | $322.5M | $162.3M | $117.7M | $9.1M | -$24.2M | $34.0M | $77.0M | $77.7M | $54.4M | $41.2M |
| Interest expense | — | — | $55.5M | $48.4M | $36.6M | $34.9M | $24.8M | $270,000 | $274,000 | — |
| Income tax | $62.2M | $19.3M | $19.3M | -$12.0M | -$22.5M | -$4.7M | $3.5M | $1.9M | $4.8M | $13.7M |
| Net income | $215.2M | $96.7M | $55.7M | -$26.1M | -$44.3M | $8.8M | $39.7M | $73.9M | $47.4M | $26.4M |
| EPS (diluted) | $2.46 | $1.09 | $0.64 | $-0.31 | $-0.53 | $0.12 | $0.58 | $1.17 | $0.77 | $0.44 |
| Operating cash flow | $457.1M | $339.9M | $242.8M | $150.7M | $141.0M | $181.6M | $105.0M | $113.4M | $81.7M | $45.6M |
| Free cash flow | $455.1M | $337.8M | $241.1M | $147.3M | $132.1M | $168.5M | $97.7M | $109.6M | $76.2M | $41.9M |
| Cash & equivalents | $318.9M | $295.9M | $404.0M | $254.3M | $225.4M | $328.8M | $191.7M | $361.5M | $199.5M | $140.0M |
| Inventory | — | — | — | — | — | — | — | — | $215,000 | $592,000 |
| Total assets | $3.4B | $3.4B | $3.2B | $3.1B | $3.1B | $2.7B | $2.6B | $510.0M | $369.2M | $279.1M |
| Total liabilities | $1.3B | $1.3B | $1.1B | $1.2B | $1.3B | $1.3B | $1.5B | $32.9M | $22.9M | $17.2M |
| Shareholders' equity | $2.1B | $2.1B | $2.0B | $1.9B | $1.9B | $1.4B | $1.0B | $477.1M | $346.3M | $261.9M |
Growth · year-over-year · Revenue CAGR 24.8%
| Metric | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue growth | +9.5% | +20.0% | +16.0% | +13.9% | +3.1% | +37.9% | +85.2% | +25.1% | +28.7% | +40.7% |
| Net income growth | +122.5% | +73.6% | — | — | -601.3% | -77.7% | -46.3% | +56.0% | +79.6% | +58.8% |
| EPS growth | +125.7% | +70.3% | — | — | -541.7% | -79.3% | -50.4% | +51.9% | +75.0% | +57.1% |
| Free cash flow growth | +34.7% | +40.1% | +63.7% | +11.5% | -21.6% | +72.5% | -10.8% | +43.7% | +81.8% | +73.6% |
Each column is the change versus the prior fiscal year. Growth off a negative or zero base is shown as “—”. CAGR is the compound annual revenue growth across the years shown.
Computed from company filings · US · as of 2026-01-31. Facts plus Stocktoria's own computed scores — not investment advice.